SEC Filing Summary: Zapata Corporation (10-Q)
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended December 31, 1997, for Zapata Corporation. The registrant is a Delaware corporation primarily engaged in marine protein harvesting and production through its subsidiary, Omega Protein Corporation. The filing notes a strategic shift away from energy operations (Bolivian oil and gas interests were sold in July 1997) toward food services. On January 27, 1998, the company announced an initial public offering (IPO) registration for Omega Protein.
Key Financial Metrics
| Metric | Q1 1998 (Ended Dec 31) | Q1 1997 (Ended Dec 31) |
|---|---|---|
| Revenues | $29.5 million | $25.6 million |
| Operating Income | $8.2 million | $3.2 million |
| Net Income | $4.6 million | $1.9 million |
| Diluted EPS | $0.19 | $0.07 |
| Cash from Operations | $2.7 million | $0.1 million |
| Cash & Equivalents (End of Period) | $28.0 million | $101.9 million |
| Working Capital | $62.0 million | $86.4 million (Sep 30, 1997) |
| Total Debt (Current + Long-term) | $12.8 million | $12.3 million (Sep 30, 1997) |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 15% year-over-year, driven by higher sales volumes and selling prices for fish meal and fish oil products.
- Profitability Surge: Operating income more than doubled to $8.2 million, and net income increased to $4.6 million. This was primarily due to improved performance in marine protein operations.
- Price Increases: Average selling prices for regular grade fish meal rose 8%, special select fish meal rose 9%, and crude fish oil rose 31% compared to the prior year.
- Investing Outflows: Net cash used in investing activities was $28.3 million, compared to $0.5 million provided in the prior year. This was due to the acquisition of American Protein ($14.5 million) and Gulf Protein ($13.6 million) assets.
- Liquidity Decline: Cash and cash equivalents dropped from $55.6 million to $28.0 million during the quarter, largely due to the $28.1 million spent on asset acquisitions.
Outlook, Risks, and Unusual Items
- Strategic IPO: Omega Protein Corporation filed a Form S-1 for an IPO of 6 million shares. Proceeds are expected to repay approximately $33.3 million in intercompany debt owed to Zapata. Post-offering, Zapata expects to retain approximately 75% ownership.
- Acquisition Integration: Zapata is integrating assets from American Protein and Gulf Protein. The Gulf Protein plant is being upgraded for specialty meals, with operations expected to begin in the 1998 fishing season.
- Equity Losses: The company recorded a $1.1 million equity loss from its 40% interest in Envirodyne Industries, Inc., compared to a $1.3 million loss in the prior year.
- Litigation Risks:
- Harwin/Crandon Case: Derivative actions alleging breach of fiduciary duty regarding the Envirodyne investment and business strategy shifts. Zapata intends to defend vigorously.
- Holt Petition: Former directors allege misrepresentations regarding the sale of Energy Industries, seeking damages estimated between $54 million and over $100 million. Trial date is pending.
- Market Risks: Product prices are heavily influenced by global supply and demand for soybean meal and vegetable oils, over which the company has no control.
Investor Verification Checklist
- Acquisition Synergies: Verify the timeline and cost of integrating the American Protein and Gulf Protein assets and the projected revenue contribution from the upgraded Morgan City plant.
- Omega Protein IPO: Confirm the status of the S-1 registration, the final offering price, and the exact percentage of ownership Zapata will retain post-IPO.
- Commodity Exposure: Assess the sensitivity of future margins to fluctuations in soybean meal and vegetable oil prices.
- Litigation Exposure: Review the potential financial impact of the Harwin/Crandon and Holt cases, specifically the risk of damages exceeding $100 million in the Holt case.
- Envirodyne Performance: Monitor the financial health of Envirodyne Industries, given Zapata's 40% stake and recurring equity losses.